About Us
INNOVATIVE
REGIONAL
HEALTHCARE
GROUP.
EP Plus Group is a REGIONAL HEALTHCARE CORPORATION BASED IN MALAYSIA, WITH A ROBUST FOOTHOLD IN SINGAPORE, INDONESIA AND EXPANDING ACROSS
SOUTHEAST ASIA.
Since our inception in 1997, we are driven by our mission to make innovative European medical possibilities - pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.
With over 25 years’ experience, we have built more than 10 niche European brands from zero to market leaders through our 3 business units - Pharmaceuticals, Fertility Sciences and Medical Aesthetics.

“Today, we are the exclusive distributor of more than 15 principals and 30 brands, with a vast network of over 10,000 healthcare professionals.”
OUR VISION, MISSION &
COMMITTMENT

OUR MISSION
ENHANCING
LIVES
THROUGH
PHARMA AND
MEDICAL
PRODUCTS.

OUR VISION
THE LEADING
HEALTHCARE
GROUP IN
SOUTHEAST
ASIA.
WE ARE COMMITTED TO
MAKING A DIFFERENCE
IN IMPROVING LIVES
THROUGH BETTER DISEASE
MANAGEMENT AND
TREATMENT OUTCOME.
Achieving better disease management and treatment outcomes, together with our healthcare professionals.
Adding value to the lives of our patients, employees, customers, partners and community.
Ultimately, making a difference in improving and enhancing lives that we touch along the way.
OUR FOOTPRINTS
MAKING OUR MARK.
GROWING OUR REACH.
Our strong foothold in Malaysia fuelled our capability to rapidly expand our base to Singapore and Indonesia.
We aspire to further expand our footprints to Thailand, Vietnam and Philippines by 2025.
1997
MALAYSIA
2010
SINGAPORE
2015
INDONESIA
COMING SOON
VIETNAM
THAILAND
PHILIPINES
OUR STORY BEGINS

OUR STORY BEGINS
1ST JULY 1997
INCORPORATED PHARMA BUSINESS IN KUALA LUMPUR - EMERGING PHARMA SDN BHD
Tse-Ming (Mr) PANG, a pharmacist entrepreneur with varied experience in pharmaceutical sales and marketing, and Siew-Mee (Ms) LIM, a banker, established “Emerging Pharma Sdn Bhd” to introduce European pharmaceuticals to healthcare professionals trained in the British medical system.
STRATEGIC BUSINESS UNIT FORMATION

STRATEGIC BUSINESS UNIT FORMATION
22ND JANUARY 2003
ESTABLISHED MEDICAL AESTHETIC DIVISION - PARVUS SDN BHD.
Spinning off from the Botulinum Toxin product’s medical indications, PARVUS introduced the medical aesthetic indications to specialists, offering minimally invasive procedures that help people “Look and Feel Better”.
Brendan PANG, General Manager for PARVUS, expanded the aesthetic business to Singapore and Indonesia.
STRATEGIC BUSINESS UNIT FORMATION

STRATEGIC BUSINESS UNIT FORMATION
JULY 2006
INITIATED ASSISTED REPRODUCTIVE TECHNOLOGY DIVISION - EMERGING PHARMA ART
Started fertility business to provide culture media. Expanded to lab wares and time-lapsed monitoring system to help embryologists and fertility doctors culture embryos and select the strongest embryo for implantation.
CORPORATE REBRANDING EXERCISE

CORPORATE REBRANDING EXERCISE
JULY 2008
REBRANDED EMERGING PHARMA TO EP PLUS GROUP
Re-strategised and rebranded to EP PLUS GROUP with new fine-tuned vision, mission and strategic directions for the group.
EXTENDED FOOTPRINT TO SINGAPORE

EXTENDED FOOTPRINT TO SINGAPORE
10TH MAY 2010
Formation of EP PLUS (S) PTE LTD and officiated the business expansion into Singapore with our medical aesthetics and assisted reproductive technology range of products.
BUSINESS ACQUISITION IN INDONESIA

BUSINESS ACQUISITION IN INDONESIA
27TH APRIL 2015
FORMATION OF TRADE REPRESENTATIVE OFFICE (TRO) IN INDONESIA.
Acquired Universal Aesthetica Indonesia’s aesthetic business and formed PT PARVUS Medica Indonesia, 28th Nov 2017 with a full commercial team in Indonesia.
IT’S ALL ABOUT PEOPLE AND CULTURE

IT’S ALL ABOUT PEOPLE AND CULTURE
MAY 2019
THE GREAT WORKPLACE AND CULTURE TREE LAUNCHED
Transformed our 26,000 sq ft office space into our Southeast Asian headquarters. Propagating “The EP Plus WAY”, the way we do things here, with the introduction of our “EP Plus Culture Tree”.